Editorial & Opinion
Response to Sensitivity of the Glycemia Risk Index to Effects of Automated Insulin Delivery Initiation.
| العنوان: | Response to Sensitivity of the Glycemia Risk Index to Effects of Automated Insulin Delivery Initiation. |
|---|---|
| المؤلفون: | Klonoff DC; Diabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, CA, USA., Kohn MA; University of California, San Francisco, San Francisco, CA, USA., Rodbard D; Biomedical Informatics Consultants LLC, Potomac, MD, USA., Aaron RE; Diabetes Technology Society, Burlingame, CA, USA., Tian T; Diabetes Technology Society, Burlingame, CA, USA. |
| المصدر: | Journal of diabetes science and technology [J Diabetes Sci Technol] 2024 Mar; Vol. 18 (2), pp. 528-529. Date of Electronic Publication: 2023 Dec 24. |
| نوع المنشور: | Letter |
| اللغة: | English |
| بيانات الدورية: | Publisher: Sage Country of Publication: United States NLM ID: 101306166 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1932-2968 (Electronic) Linking ISSN: 19322968 NLM ISO Abbreviation: J Diabetes Sci Technol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2014- : Thousand Oaks, CA : Sage Original Publication: Foster City, CA : Diabetes Technology Society |
| مواضيع طبية MeSH: | Insulin*/adverse effects , Insulin, Regular, Human*, Humans |
| مستخلص: | Competing Interests: Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: DCK is a consultant for Afon, Better Therapeutics, Integrity, Lifecare, Nevro, Novo, and Thirdwayv. DR is a consultant to Eli Lilly & Co. Inc. and Better Therapeutics, Inc. He has previously provided consulting services to multiple companies and organizations developing glucose meters, continuous glucose monitors, insulin pumps, digital connected insulin pens, and systems for automated insulin delivery, data analytics, clinical decision support, and other technologies to assist in the medical management of people with diabetes. The remaining authors have nothing to disclose. |
| References: | Diabetes Technol Ther. 2022 Jun;24(6):424-434. (PMID: 35294272) Intern Med J. 2024 Jan;54(1):121-128. (PMID: 37255209) J Diabetes Sci Technol. 2023 Sep;17(5):1226-1242. (PMID: 35348391) Diabetes Care. 2021 Mar;44(3):844-846. (PMID: 33431420) J Diabetes Sci Technol. 2024 Jan;18(1):242-243. (PMID: 37932939) Diabetes Care. 2019 Aug;42(8):1593-1603. (PMID: 31177185) |
| فهرسة مساهمة: | Keywords: automated insulin delivery; continuous glucose monitor; diabetes; glycemia risk index; time in range |
| المشرفين على المادة: | 0 (Insulin) 0 (Insulin, Regular, Human) |
| تواريخ الأحداث: | Date Created: 20231224 Date Completed: 20240304 Latest Revision: 20240330 |
| رمز التحديث: | 20240330 |
| مُعرف محوري في PubMed: | PMC10973854 |
| DOI: | 10.1177/19322968231220064 |
| PMID: | 38142366 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1932-2968 |
|---|---|
| DOI: | 10.1177/19322968231220064 |